BRIDGEWAY CAPITAL MANAGEMENT, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 37 filers reported holding OVID THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,761,408
-33.0%
458,700
-42.7%
0.04%
-31.7%
Q2 2023$2,627,779
+23.1%
801,152
-3.2%
0.06%
+10.5%
Q1 2023$2,135,156
+26.0%
827,580
-9.2%
0.06%
+29.5%
Q4 2022$1,694,832
+1.4%
911,200
+0.3%
0.04%
-2.2%
Q3 2022$1,672,000
-20.9%
908,500
-7.6%
0.04%
-6.2%
Q2 2022$2,115,000
+83.0%
983,700
+167.2%
0.05%
+118.2%
Q1 2022$1,156,000
+70.3%
368,100
+74.1%
0.02%
+69.2%
Q4 2021$679,000
-4.4%
211,4000.0%0.01%
-7.1%
Q3 2021$710,000
-14.1%
211,4000.0%0.01%
-6.7%
Q2 2021$827,000
-10.3%
211,400
-7.8%
0.02%
-11.8%
Q1 2021$922,000
+27.5%
229,400
-5.4%
0.02%0.0%
Q1 2020$723,000
-28.2%
242,6000.0%0.02%
+21.4%
Q4 2019$1,007,000
+47.9%
242,600
+15.4%
0.01%
+55.6%
Q3 2019$681,000
+513.5%
210,200
+249.2%
0.01%
+800.0%
Q2 2019$111,000
-25.5%
60,200
-28.7%
0.00%
-50.0%
Q1 2019$149,000
-37.4%
84,440
-14.2%
0.00%
-33.3%
Q4 2018$238,000
-61.3%
98,440
-9.2%
0.00%
-50.0%
Q3 2018$615,000
-27.3%
108,4400.0%0.01%
-33.3%
Q2 2018$846,000
+10.3%
108,4400.0%0.01%
+12.5%
Q1 2018$767,000
+58.5%
108,440
+121.3%
0.01%
+60.0%
Q4 2017$484,00049,0000.01%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders